PhD Program
Scientists and Projects
Departments and Host Institutions
Application Procedures
Search
Scientists and Projects
Sergio Abrignani
Silvia Barabino
Giorgio Battaglia
Andrea Becchetti
Ettore Biagi
Giorgio Biasi
Andrea Biondi
Francesco Broccolo
Silvia Brunelli
Maurizio C. Capogrossi
Giorgio Cattoretti
Guido Cavaletti
Clementina Cocuzza
Marco Crimi
Carlo Ferrarese
Giuliana Ferrari
Alessandra Ferri
Gaetano Finocchiaro
Katharina Fleischhauer
Maria Foti
Alberto Froio
Carlo Gambacorti-Passerini
Paolo Ghia
Gabriella Giagnoni
Roberto Giovannoni
Josée Golay
Francesca Granucci
Martino Introna
Marialuisa Lavitrano
Marzia Maria Lecchi
Renato Mantegazza
Massimo Masserini
Raffaela Meneveri
Paolo Mingazzini
Giuseppe Miserocchi
Monica Moro
Rosario Musumeci
Silvia Kirsten Nicolis
Sergio Ottolenghi
Gianfranco Parati
Marco Parenti
Roberto A. Perego
Maurizio Pesce
Antonio Pesenti
Alberto Piperno
Giulio Pompilio
Maria Pia Protti
Eva Reali
Paola Ricciardi-Castagnoli
Ilaria Rivolta
Antonella Ronchi
Elena Irene Rugarli
Giulio Alfredo Sancini
Valeria Tiranti
Antonio Torsello
Angelo Vescovi
Ivan Zanoni
Antonio Zaza
Massimo Zeviani
Name: Maurizio Pesce
E-mail: maurizio.pesce@ccfm.it
Department: Istituto Cardiologico Monzino, Milano Italy
Research Area(s): Stem cells from the human heart, HDAC inhibitors

Research Projects

Isolation and characterization of stem cells from the human heart

The scope of this project is that of isolating and characterize progenitor cells that may be used for heart repair following acute or chronic ischemia. In this project the features of adult human heart-derived stem cells will be assessed in vitro by immunophenotyping and molecular analyses. Further, a correlation between clonogenicity of heart-derived stem cells and occurrence of risk factors in donor patients will be performed.

Histone deacetylase activity, stemness control and endothelial programming of cord blood and bone marrow-derived uncommitted progenitors

The scope of this project is that of understanding how epigenetic modifications, like those elicited by treatment with drugs inhibiting the cellular histone deacetylase (HDAC inhibitors), contribute to programming and reprogramming of endothelial phenotype in uncommitted progenitor cells. Starting from assessment of stemness of HDACi-treated cells in culture, the project will unravel the possible phenotypic changes as well as the preclinical relevance of HDACi treatment for induction of angiogenesis. Besides unravelling regulatory networks involved in stemness control and differentiation, this project, if successful will lead to important advancement in cellular therapies of ischemic diseases, such as critical limb ischemia and heart ischemic disease.
© 2003-2007 dimet.org
Site created by ScienceDev and based on Easy Manager